<a href="https://laohu8.com/S/00897">Wai Yuen Tong</a> Medicine Holdings revenue falls 6.9% with profit down 88.2%
Wai Yuen Tong Medicine Holdings Limited reported revenue of HK$322.8 million for the six months ended 30 September 2025, a decrease of 6.9% compared to HK$346.8 million in the same period last year. Gross profit declined by 9.2% to HK$165.3 million. Profit attributable to owners of the parent fell 88.2% to HK$2.8 million. Basic and diluted earnings per share were 0.25 HK cents, compared to 2.10 HK cents previously. As of 30 September 2025, the Group's net asset value was HK$1,181.5 million and cash and cash equivalents stood at HK$121.2 million. The principal activities during the period included the production and sale of Chinese pharmaceutical and health food products, provision of Traditional Chinese Medicine services, and management and promotion services, mainly in Mainland China and Hong Kong.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Yuen Tong Medicine Holdings Limited published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251124-11926696), on November 24, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。